Literature DB >> 20430851

Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases.

Damien Galanaud1, S Haik, M G Linguraru, J-P Ranjeva, B Faucheux, E Kaphan, N Ayache, J Chiras, P Cozzone, D Dormont, J-P Brandel.   

Abstract

BACKGROUND AND
PURPOSE: The physiopathologic bases underlying the signal intensity changes and reduced diffusibility observed in prion diseases (TSEs) are still poorly understood. We evaluated the interest of MRS combined with DWI both as a diagnostic tool and a way to understand the mechanism underlying signal intensity and ADC changes in this setting.
MATERIALS AND METHODS: We designed a prospective study of multimodal MR imaging in patients with suspected TSEs. Forty-five patients with a suspicion of TSE and 11 age-matched healthy volunteers were included. The MR imaging protocol included T1, FLAIR, and DWI sequences. MRS was performed on the cerebellum, pulvinar, right lenticular nucleus, and frontal cortex. MR images were assessed visually, and ADC values were calculated.
RESULTS: Among the 45 suspected cases, 31 fulfilled the criteria for probable or definite TSEs (19 sCJDs, 3 iCJDs, 2 vCJDs, and 7 genetic TSEs); and 14 were classified as AltDs. High signals in the cortex and/or basal ganglia were observed in 26/31 patients with TSEs on FLAIR and 29/31 patients on DWI. In the basal ganglia, high DWI signals corresponded to a decreased ADC. Metabolic alterations, increased mIns, and decreased NAA were observed in all patients with TSEs. ADC values and metabolic changes were not correlated; this finding suggests that neuronal stress (vacuolization), neuronal loss, and astrogliosis do not alone explain the decrease of ADC.
CONCLUSIONS: MRS combined with other MR imaging is of interest in the diagnosis of TSE and provides useful information for understanding physiopathologic processes underlying prion diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20430851      PMCID: PMC7965471          DOI: 10.3174/ajnr.A2069

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  36 in total

1.  MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study.

Authors:  A Krasnianski; K Kallenberg; D A Collie; B Meissner; W J Schulz-Schaeffer; U Heinemann; D Varges; D M Summers; H A Kretzschmar; T Talbot; R G Will; I Zerr
Journal:  Eur J Neurol       Date:  2008-08       Impact factor: 6.089

2.  Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

Authors:  P Parchi; A Giese; S Capellari; P Brown; W Schulz-Schaeffer; O Windl; I Zerr; H Budka; N Kopp; P Piccardo; S Poser; A Rojiani; N Streichemberger; J Julien; C Vital; B Ghetti; P Gambetti; H Kretzschmar
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

3.  A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases.

Authors:  S Confort-Gouny; J Vion-Dury; F Nicoli; P Dano; A Donnet; N Grazziani; J L Gastaut; F Grisoli; P J Cozzone
Journal:  J Neurol Sci       Date:  1993-09       Impact factor: 3.181

4.  Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease.

Authors:  G D Graham; O A Petroff; A M Blamire; G Rajkowska; P Goldman-Rakic; J W Prichard
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

5.  MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study.

Authors:  R K Fulbright; C Hoffmann; H Lee; A Pozamantir; J Chapman; I Prohovnik
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-17       Impact factor: 3.825

Review 6.  Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease.

Authors:  Y Shiga; K Miyazawa; S Sato; R Fukushima; S Shibuya; Y Sato; H Konno; K Doh-ura; S Mugikura; H Tamura; S Higano; S Takahashi; Y Itoyama
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

7.  Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease.

Authors:  K L Behar; R Boucher; W Fritch; L Manuelidis
Journal:  Magn Reson Imaging       Date:  1998-10       Impact factor: 2.546

8.  Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.

Authors:  T Billette de Villemeur; A Gelot; J P Deslys; D Dormont; C Duyckaerts; L Jardin; J Denni; O Robain
Journal:  Neuropathol Appl Neurobiol       Date:  1994-04       Impact factor: 8.090

9.  MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.

Authors:  Kerry A Broom; Daniel C Anthony; John P Lowe; Julian L Griffin; Helen Scott; Andrew M Blamire; Peter Styles; V Hugh Perry; Nicola R Sibson
Journal:  Neurobiol Dis       Date:  2007-04-05       Impact factor: 5.996

10.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  K T M Fernando; M A McLean; D T Chard; D G MacManus; C M Dalton; K A Miszkiel; R M Gordon; G T Plant; A J Thompson; D H Miller
Journal:  Brain       Date:  2004-05-05       Impact factor: 13.501

View more
  13 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

Review 2.  Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?

Authors:  Pavlina Sobrova; Iva Blazkova; Jana Chomoucka; Jana Drbohlavova; Marketa Vaculovicova; Pavel Kopel; Jaromir Hubalek; Rene Kizek; Vojtech Adam
Journal:  Prion       Date:  2013-09-20       Impact factor: 3.931

3.  Temporal evolution of sporadic Creutzfeldt-Jakob disease monitored by 3-Tesla MR spectroscopy.

Authors:  Koji Fujita; Masafumi Harada; Tatsuhiko Yuasa; Makoto Sasaki; Yuishin Izumi; Ryuji Kaji
Journal:  J Neurol       Date:  2011-02-17       Impact factor: 4.849

4.  Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt-Jakob disease: correlation with clinical course.

Authors:  Jae Hyoung Kim; Byung Se Choi; Cheolkyu Jung; YoungHee Chang; SangYun Kim
Journal:  Neuroradiology       Date:  2011-01-11       Impact factor: 2.804

Review 5.  Neuroradiology of human prion diseases, diagnosis and differential diagnosis.

Authors:  Simona Gaudino; Emma Gangemi; Raffaella Colantonio; Annibale Botto; Emanuela Ruberto; Rosalinda Calandrelli; Matia Martucci; Maria Gabriella Vita; Carlo Masullo; Alfonso Cerase; Cesare Colosimo
Journal:  Radiol Med       Date:  2017-01-21       Impact factor: 3.469

6.  In Vivo Longitudinal (1)H MRS Study of Transgenic Mouse Models of Prion Disease in the Hippocampus and Cerebellum at 14.1 T.

Authors:  Cristina Cudalbu; Melanie Craveiro; Vladimir Mlynárik; Juliane Bremer; Adriano Aguzzi; Rolf Gruetter
Journal:  Neurochem Res       Date:  2015-07-23       Impact factor: 3.996

Review 7.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

Review 9.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

10.  White matter involvement in sporadic Creutzfeldt-Jakob disease.

Authors:  Eduardo Caverzasi; Maria Luisa Mandelli; Stephen J DeArmond; Christopher P Hess; Paolo Vitali; Nico Papinutto; Abby Oehler; Bruce L Miller; Irina V Lobach; Stefano Bastianello; Michael D Geschwind; Roland G Henry
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.